Skip to main content
Toggle navigation
Login
Search
Home
Program Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Full Schedule
Home
Full Schedule
All Days
Wed, Apr 3
Thu, Apr 4
Fri, Apr 5
Sat, Apr 6
Full Schedule
Type here to filter the list
Friday, April 5, 2024
6:30 AM – 7:30 AM
ET
Yoga
6:30 AM – 7:30 AM
ET
Easy Flow Yoga
Location: 111 - 112
7:00 AM – 8:00 AM
ET
CE Symposium: Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3 and TROP2: Strategies for Oncology Pharmacists
7:00 AM – 8:00 AM
ET
CE Symposium: Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3 and TROP2: Strategies for Oncology Pharmacists
Location: 124-125
*Speaker:
Allison Butts, PharmD, BCOP
– UK HealthCare
*Speaker:
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
CE: 1
7:00 AM – 8:00 AM
ET
CE Symposium: Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and Safety Measures
7:00 AM – 8:00 AM
ET
CE Symposium: Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and Safety Measures
Location: 120-121
Co-Speaker:
James A. Davis, PharmD, BCOP
– Medical University of South Carolina
Co-Speaker:
Matthew Chui, PharmD, BCOP
– University of Miami Sylvester Comprehensive Cancer Center
Co-Speaker:
Michael Buege, PharmD, BCOP
– University of Illinois Chicago
CE: 1
7:00 AM – 8:00 AM
ET
CE Symposium: Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based Care
7:00 AM – 8:00 AM
ET
CE Symposium: Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based Care
Location: 122-123
Co-Speaker:
Sara Moran Smith, PharmD, BCOP
Co-Speaker:
Sarah E. Profitt, PharmD, BCPS, BCOP
– Memorial Sloan Kettering Cancer Center
Co-Speaker:
Julio Chavez, MD
CE: 1
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Ambulatory
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Ambulatory
Location: 116
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Breast Cancer
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Breast Cancer
Location: 117
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Cerner Oncology Users
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Cerner Oncology Users
Location: 114
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Industry Professionals
7:00 AM – 8:00 AM
ET
Special Interest Group (SIG) - Industry Professionals
Location: 115
8:15 AM – 9:30 AM
ET
New Flavors: Bites in Hematologic Malignancies
8:15 AM – 9:30 AM
ET
301 - New Flavors: Bites in Hematologic Malignancies
Location: Ballroom A
Co-Speaker:
Melissa Royero, PharmD (she/her/hers)
– OhioHealth Riverside Methodist Hospital
Co-Speaker:
Soniya Chandrasekhara, PharmD., BCOP (she/her/hers)
– Stanford Healthcare
Co-Speaker:
Shahrier Hossain, PharmD, BCOP
– Dana-Farber Cancer Institute
Co-Speaker:
Kelsea Seago, PharmD, BCOP (she/her/hers)
– WVU Medicine
CE: 1.25
8:15 AM – 9:30 AM
ET
Pharmacology and Clinical Application of Complement Inhibitors
8:15 AM – 9:30 AM
ET
BC5 - Pharmacology and Clinical Application of Complement Inhibitors
Location: Ballroom B-C
Co-Speaker:
Binni Kunvarjee, PharmD, BCOP (she/her/hers)
– Memorial Sloan Kettering Cancer Center
Co-Speaker:
Justin R. Arnall, PharmD, BCOP
– Specialty Pharmacy Service, Atrium Health
CE: 1.25
9:40 AM – 10:40 AM
ET
1 - Ethical Dilemmas in Oncology Pharmacy: When Science and Morals Collide
9:40 AM – 10:40 AM
ET
302-A - Ethical Dilemmas in Oncology Pharmacy: When Science and Morals Collide
Location: Ballroom B-C
Speaker:
Karen M. Fancher, PharmD, BCOP
– Duquesne University School of Pharmacy
CE: .50
9:40 AM – 10:40 AM
ET
2 - The Gene Therapy Odyssey: Preparing the Pharmacist for New Horizons
9:40 AM – 10:40 AM
ET
302-B - The Gene Therapy Odyssey: Preparing the Pharmacist for New Horizons
Location: Ballroom B-C
Speaker:
Abby Kim, PharmD, BCOP (she/her/hers)
– CenterWell Specialty Pharmacy
CE: .50
9:40 AM – 10:40 AM
ET
3 - Bispecifics in Lymphoma
9:40 AM – 10:40 AM
ET
303-A - Bispecifics in Lymphoma
Location: Ballroom A
Speaker:
Aseala Abousaud, PharmD, BCOP (she/her/hers)
– Emory Winship Cancer Institute
CE: .50
9:40 AM – 10:40 AM
ET
4 - Taking a Bite Out of Myeloma: The Role of Bi-Specific Antibodies in the Treatment of Relapsed/Refractory Multiple Myeloma
9:40 AM – 10:40 AM
ET
303-B - Taking a Bite Out of Myeloma: The Role of Bi-Specific Antibodies in the Treatment of Relapsed/Refractory Multiple Myeloma
Location: Ballroom A
Speaker:
Brooke Adams, PharmD, BCOP (she/her/hers)
– Orlando Health Cancer Institute
CE: .50
9:40 AM – 10:40 AM
ET
5 - Updates in the Management of Endometrial Cancer
9:40 AM – 10:40 AM
ET
304-A - Updates in the Management of Endometrial Cancer
Location: Ballroom D
Speaker:
Emily Graham, PharmD, BCOP, MS (she/her/hers)
– Allegheny Health Network Cancer Institute
CE: .50
9:40 AM – 10:40 AM
ET
6 - Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer Treatment
9:40 AM – 10:40 AM
ET
304-B - Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer Treatment
Location: Ballroom D
Speaker:
Danielle Roman, PharmD, BCOP (she/her/hers)
– Allegheny Health Network
CE: .50
10:50 AM – 11:50 AM
ET
John G. Kuhn Keynote Address: Dr. Glaucomflecken "Wife & Death & Comedy"
10:50 AM – 11:50 AM
ET
John G. Kuhn Keynote Address: Dr. Glaucomflecken "Wife & Death & Comedy"
Location: Ballroom B-C
Keynote Speaker:
Will "Dr. G" Flanary, MD
– Eye Health Northwest
11:50 AM – 2:15 PM
ET
Exhibit Hall and Lunch
11:50 AM – 2:15 PM
ET
Exhibit Hall and Lunch
Location: Exhibit Hall
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
Location: 124-125
*Speaker:
Rodney J. Hunter, PharmD, BCOP
– Texas Southern University College of Pharmacy and Health Sciences
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Practical Management of AML with a BCL-2 Inhibitor
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Practical Management of AML with a BCL-2 Inhibitor
Location: 122-123
*Speaker:
Cory Vela, PharmD, BCOP
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)
12:00 PM – 1:00 PM
ET
Non-CE Symposium: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)
Location: 120-121
Co-Speaker:
David Sallman, MD
Co-Speaker:
Katie Tobon, PharmD, BCOP
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Classical Hematology
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Classical Hematology
Location: 117
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Investigational Drug Services (IDS)
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Investigational Drug Services (IDS)
Location: 115
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Residency Program Directors (RPD)
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Residency Program Directors (RPD)
Location: 114
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Trainee
12:00 PM – 1:00 PM
ET
Special Interest Group (SIG) - Trainee
Location: 116
12:00 PM – 2:00 PM
ET
Poster Session: Trainee Research
12:00 PM – 2:00 PM
ET
Poster Session: Trainee Research
Location: Exhibit Hall
2:15 PM – 3:00 PM
ET
Incoming President's Remarks
2:15 PM – 3:00 PM
ET
Incoming President's Remarks
Location: Ballroom B-C
*Speaker:
Jolynn K. Sessions, PharmD, BCOP, FHOPA
– Charles George VA Medical Center
3:15 PM – 4:15 PM
ET
Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine
3:15 PM – 4:15 PM
ET
BC6 - Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine
Location: Ballroom B-C
Speaker:
Tara Higgins, PharmD, BCPPS, FPPA, FFSHP (she/her/hers)
– Lake Erie College of Osteopathic Medicine School of Pharmacy
CE: 1
3:15 PM – 4:15 PM
ET
Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder Cancer
3:15 PM – 4:15 PM
ET
305 - Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder Cancer
Location: Ballroom A
Speaker:
Kelly M. Brunk, PharmD, BCOP (he/him/his)
– The University of Kansas Cancer Center
CE: 1
6:00 PM – 9:00 PM
ET
HOPA's 20th Anniversary Gala
6:00 PM – 9:00 PM
ET
HOPA's 20th Anniversary Celebration